A scoring system based on inflammatory and nutritional indicators to predict the long-term survival of patients with non-metastatic nasopharyngeal carcinoma-Reference-Cited by-同舟云学术

A scoring system based on inflammatory and nutritional indicators to predict the long-term survival of patients with non-metastatic nasopharyngeal carcinoma

Published:2024-08-30 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Fang Wei-ning,Wu Hai-xia,Wu Zhu-peng,Fei Zhao-dong,Zhao Dan,Chen Fei,Lin Cheng,Ma Li-qin

Funder

National Clinical Key Specialty Construction Program, Fujian Provincial Clinical Research Center for Cancer Radiotherapy and Immunotherapy

Fujian Clinical Research Center for Radiation and Therapy of Digestive, Respiratory and Genitourinary Malignancies

the National Clinical Key Specialty Construction Program

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-71360-z.pdf

Reference19 articles.

1. Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74(3), 229–263 (2024).

2. He, Q. et al. A novel prognostic marker based on risk stratification with prognostic nutritional index and age for nasopharyngeal carcinoma patients who received neoadjuvant chemotherapy. Biomark. Med. 13(12), 1013–1023 (2019).

3. Chen, Y. P. et al. Nasopharyngeal carcinoma. Lancet 394(10192), 64–80 (2019).

4. Wei, W. et al. Pretreatment Epstein-Barr virus DNA load and cumulative cisplatin dose intensity affect long5-term outcome of nasopharyngeal carcinoma treated with concurrent chemotherapy: Experience of an institute in an endemic area. Oncol. Res. Treat. 37, 88 (2014).

5. Wang, W. Y. et al. Long-term survival analysis of nasopharyngeal carcinoma by plasma Epstein-Barr virus DNA levels. Cancer 119(5), 963–970 (2013).